Applied DNA Reports Third Quarter Fiscal 2025 Financial Results

August 14, 2025 4:10 PM

Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company focused on providing nucleic acid production solutions for the biopharmaceutical and diagnostics industries, today reported financial results for its third quarter of fiscal 2025 ended June 30, 2025. The Company's Form 10-Q for its fiscal third quarter can be viewed on the SEC Filings page of its Investor Relations website. The Company will not...

Read more

CLUB4 Fitness Strengthens Executive Team With Key Promotions to Fuel Expansion

August 14, 2025 3:00 PM

CLUB4 Fitness, one of the fastest-growing fitness brands in the U.S., today announced a series of key executive promotions designed to support its continued growth and enhance the member experience. The company has promoted Stephanie Strachan to Chief Operating Officer (COO) and appointed three new Vice Presidents to its leadership team.Stephanie Strachan's promotion to COO is effective immediately. Her appointment follows a transformative...

Read more

CNS Pharmaceuticals to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

August 14, 2025 9:15 AM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that it will present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech being held virtually August 19-21, 2025Details for the presentation are as follows:Date and Time: Tuesday, August...

Read more

Surgical Tourism: Board-Certified Plastic Surgeon Dr. Meegan Gruber Warns of Hidden Patient Risks

August 14, 2025 9:00 AM

Dr. Meegan Gruber, MD, PhD, who serves as a Board-Certified Plastic Surgeon warns patients to research all safety aspects of surgical tourism prior to scheduling foreign procedures. Each year approximately 150,000 to 320,000 U.S. citizens choose to get medical treatment abroad for cosmetic surgery operations which presents multiple medical and practical and legal dangers to patients when not properly organized.The appeal of low costs and...

Read more

Wellgistics Health Terminates Equity Line of Credit to Further Support Growth Strategy

August 14, 2025 8:30 AM

Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the termination of its equity purchase agreement ("ELOC") with Hudson Global Ventures, LLC.The ELOC was an effective tool that nearly doubled the Company's original IPO raise. The decision to terminate the agreement reflects a...

Read more

Interactive Strength Inc. (Nasdaq:TRNR) Reports Second Quarter 2025 Results; Increases 2025 Pro Forma Revenue Guidance to More Than $80M

August 14, 2025 8:00 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR and FORME brands, and the pending acquirer of Sportstech, today announced financial results for its second quarter ended June 30, 2025.Quarterly Financial HighlightsFor the quarter, TRNR reported revenue of $1.2 million, a net loss of $2.2 million - or $2.13 per diluted share - and an Adjusted EBITDA loss...

Read more

Jaguar Health Reports Second Quarter 2025 Financials: Net Q2 2025 Revenue Up Approximately 35% Versus Net Q1 2025 Revenue

August 14, 2025 8:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today reported its consolidated second-quarter 2025 financial results.2025 SECOND QUARTER COMPANY FINANCIAL RESULTS:Net Prescription Products Revenue: The combined net revenue for the Company's prescription products (Mytesi®, Gelclair®, and Canalevia®-CA1) was approximately $2.9 million in the second quarter of 2025, representing an increase of approximately 36% over the combined net...

Read more

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 20

August 14, 2025 8:00 AM

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug and supplement delivery technology, today announced that Kraig Higginson, Interim Chief Executive Officer of Aspire, will be presenting at the upcoming Sidoti Virtual Investor Conference on August 20 at 1:45 PM Eastern. Investors and other interested individuals may access the virtual presentation here:...

Read more

AGFA HealthCare Empowers Future Tech Leaders Through Immersive Hands-on STEM Day for Girls in Orlando With Powerteens

August 14, 2025 4:00 AM

AGFA HealthCare, a leader in healthcare imaging IT, in partnership with Powerteens, hosted Girls in Focus: A One-Day STEM Experience on Tuesday, July 29, 2025. This unique, interactive event invited middle and high school girls from the Orlando area to explore real-world careers in healthcare IT and medical innovation through immersive demonstrations, one-on-one mentorship, and empowering conversations with women leaders in science and...

Read more

Relief Therapeutics Publishes 2025 Half-Year Report

August 14, 2025 1:20 AM

RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announced the publication of its 2025 half-year report and provided a corporate update. "Relief continued to make steady progress across our pipeline and corporate initiatives," said Dr. Raghuram Selvaraju, chairman of...

Read more

Illinois Review Board Approves Hillsboro Health Certificate of Need Application

August 13, 2025 8:00 PM

The Illinois Health Facilities and Services Review Board officially approved Hillsboro Health's Certificate of Need application for a construction project at its main hospital campus. This critical infrastructure upgrade is designed to modernize facilities, expand outpatient surgery services and ensure continued access to high-quality care for the Hillsboro community and surrounding areas.The proposed building project includes three major...

Read more

Onco-Innovations Announces Closing of Private Placement

August 13, 2025 5:00 PM

Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN:A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company") is pleased to announce that it has closed its previously-announced (see news release dated July 29, 2025) non-brokered private placement (the "Private Placement") of 243,903 units of the Company (the "Units") at a price of $1.64 per Unit, for aggregate gross proceeds of $400,000. Each Unit consists of one common share (each a "Share") and...

Read more

Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results

August 13, 2025 5:00 PM

Dermata Therapeutics, Inc. (Nasdaq:DRMA; DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment of medical skin diseases and aesthetic applications, today highlighted recent corporate progress and reported financial results for the second quarter ended June 30, 2025."We are very excited to have received the full data set from our Phase 3 STAR-1 trial of XYNGARI™ showing that XYNGARI™ achieved...

Read more

Ensysce Biosciences Reports Second Quarter 2025 Financial Results and Latest Program Updates

August 13, 2025 4:15 PM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid abuse and overdose, today reported financial and operational results for the second quarter ended June 30, 2025.Dr. Lynn Kirkpatrick, Chief Executive Officer of Ensysce, commented, "Momentum continued in the second quarter as we forged ahead...

Read more

Tenon Medical Reports Second Quarter 2025 Financial Results

August 13, 2025 4:05 PM

Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today reported financial results for the second quarter ended June 30, 2025.Financial Results and Business UpdatesSecond Quarter 2025 Results:Revenue of $0.6 million, compared to $0.9 million in the second quarter of 2024.Gross profit of $245,000, compared to $470,000 in the...

Read more

Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. Chains

August 13, 2025 4:01 PM

Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, today announced the launch of its HOCl-based diaper rash product for infants and children into large retailers in the United...

Read more

CV Sciences, Inc. Reports Second Quarter 2025 Financial Results

August 13, 2025 4:00 PM

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended June 30, 2025.Second Quarter 2025 and Recent Financial and Operating HighlightsGenerated revenue of $3.6 million for the second quarter 2025 compared to $4.0 million for...

Read more

iHealth Marketing Launches Specialized MedSpa Marketing Services to Help Medical Spas Grow and Attract More Clients

August 13, 2025 2:20 PM

iHealth Marketing, a leading medspa marketing company, today announced the launch of its MedSpa Marketing services, designed to help medical spas across the U.S. increase visibility, attract high-value clients, and boost revenue.With medical spa treatments like Botox, dermal fillers, microneedling, and body contouring seeing record demand, competition among medspas has never been greater. iHealth Marketing's new offering delivers a complete...

Read more

Trimology Reviews & Complaints 2025: Can This Ugandan-Inspired Formula Help You Shed Stubborn Fat?

August 13, 2025 1:20 PM

When it comes to achieving and maintaining a healthy weight, many people search for natural solutions that not only work but also support overall well-being. Trimology has quickly gained attention as a weight loss supplement rooted in an ancient Ugandan ritual known for curbing cravings and boosting metabolism.Designed for individuals struggling with stubborn fat, sluggish digestion, or constant hunger, Trimology offers a science-backed approach...

Read more

Johanna Altman Urges Americans to Reconsider Hidden Seed Oils in Everyday Foods

August 13, 2025 12:45 PM

Johanna Altman, founder of One Body Medicine and host of the Pure Wellness Podcast, is raising awareness about a hidden health threat lurking in everyday foods: seed oils.Following her in-depth podcast episode on the subject, Altman is advocating for more mindful eating and label awareness to help people take back control of their health and reduce the risks tied to seed oil overconsumption."Seed oils are in almost every boxed food at the...

Read more